Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit I Giasson

Showing results (61-70 of 174) with videos related to

Pageof 18
Sort By:
Acta Neuropathologica Communications|October 27, 2023
Human tauopathy strains defined by phosphorylation in R1-R2 repeat domains of tauEthan D Smith, Quan Vo, Benoit I Giasson, et al.
Plos One|September 28, 2018
Designing antibodies against LRRK2-targeted tau epitopesMatthew Hamm, Thomas B Ladd, Yona Levites, et al.
Molecular Neurodegeneration|January 5, 2017
Inflammatory pre-conditioning restricts the seeded induction of α-synuclein pathology in wild type miceEmily J Koller, Mieu M T Brooks, Todd E Golde, et al.
Neuroscience Letters|February 4, 2014
Transgenic mice expressing S129 phosphorylation mutations in α-synucleinValerie Drews Escobar, Yien-Ming Kuo, Bonnie M Orrison, et al.
The Journal of Biological Chemistry|July 18, 2002
Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathwaysZhong-Zong Pan, Wendy Bruening, Benoit I Giasson, et al.
The American Journal of Pathology|June 24, 2003
Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathiesDeepak M Sampathu, Benoit I Giasson, Aaron C Pawlyk, et al.
Annals of Neurology|September 5, 2002
Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseasesJohn E Duda, Benoit I Giasson, Meghann E Mabon, et al.
Journal of Neuropathology and Experimental Neurology|June 19, 2009
Leucine-rich repeat kinase 2 expression leads to aggresome formation that is not associated with alpha-synuclein inclusionsElisa A Waxman, Jason P Covy, Irene Bukh, et al.
The American Journal of Pathology|January 27, 2007
Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse modelErin H Norris, Kunihiro Uryu, Susan Leight, et al.
Neurobiology of Aging|December 15, 2006
Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microgliaAndis Klegeris, Steven Pelech, Benoit I Giasson, et al.
Pageof 18

Showing results (61-70 of 174) with videos related to

Sort By:
Pageof 18
Acta Neuropathologica Communications|October 27, 2023
Human tauopathy strains defined by phosphorylation in R1-R2 repeat domains of tauEthan D Smith, Quan Vo, Benoit I Giasson, et al.
Plos One|September 28, 2018
Designing antibodies against LRRK2-targeted tau epitopesMatthew Hamm, Thomas B Ladd, Yona Levites, et al.
Molecular Neurodegeneration|January 5, 2017
Inflammatory pre-conditioning restricts the seeded induction of α-synuclein pathology in wild type miceEmily J Koller, Mieu M T Brooks, Todd E Golde, et al.
Neuroscience Letters|February 4, 2014
Transgenic mice expressing S129 phosphorylation mutations in α-synucleinValerie Drews Escobar, Yien-Ming Kuo, Bonnie M Orrison, et al.
The Journal of Biological Chemistry|July 18, 2002
Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathwaysZhong-Zong Pan, Wendy Bruening, Benoit I Giasson, et al.
The American Journal of Pathology|June 24, 2003
Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathiesDeepak M Sampathu, Benoit I Giasson, Aaron C Pawlyk, et al.
Annals of Neurology|September 5, 2002
Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseasesJohn E Duda, Benoit I Giasson, Meghann E Mabon, et al.
Journal of Neuropathology and Experimental Neurology|June 19, 2009
Leucine-rich repeat kinase 2 expression leads to aggresome formation that is not associated with alpha-synuclein inclusionsElisa A Waxman, Jason P Covy, Irene Bukh, et al.
The American Journal of Pathology|January 27, 2007
Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse modelErin H Norris, Kunihiro Uryu, Susan Leight, et al.
Neurobiology of Aging|December 15, 2006
Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microgliaAndis Klegeris, Steven Pelech, Benoit I Giasson, et al.
Pageof 18